The Irish clinical trials group Icon has made its second acquisition in the space of a week, and is paying $5.8 million (€5.9 million) for YRCR, a British pharmaceutical regulatory affairs consulting group. Based in Henley in the UK, YRCR provides advice and support, including marketing authorisation applications for European, American and Japanese clients.
Icon buys second firm this week
The Irish clinical trials group Icon has made its second acquisition in the space of a week, and is paying $5
IN THIS SECTION
A Bolshoi Ballet star brings Swan Lake to Ireland: ‘Ballet is an art and it should not be political’
Irish postpunk band Gurriers: ‘Everyone asks about the Dublin music scene. It’s not just Dublin any more, it’s everywhere’
Bird director Andrea Arnold on Barry Keoghan: ‘Wow! What a face. What a man’
Jonathan Coe: ‘The morning after the election felt like waking up in a safe room, having been in an abusive relationship for 14 years’
Which house plants are best for students?
Business Today
Get the latest business news and commentary from our expert business team in your inbox every weekday morning